DXR

Daxor Corporation (DXR)

About Daxor Corporation (DXR)

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

Details

Daily high
$8.41
Daily low
$8.15
Price at open
$8.04
52 Week High
$10.04
52 Week Low
$7.19
Market cap
40.4M
Dividend yield
0.00%
Volume
1,086
Avg. volume
23,734
P/E ratio
23.68

Daxor Corporation News

Details

Daily high
$8.41
Daily low
$8.15
Price at open
$8.04
52 Week High
$10.04
52 Week Low
$7.19
Market cap
40.4M
Dividend yield
0.00%
Volume
1,086
Avg. volume
23,734
P/E ratio
23.68